Sabril (vigabatrin) - Important Safety Information from sanofi-aventis as approved by the Irish Medicines Board
05 July 2010
Important safety information communication from sanofi-aventis on abnormal brain MRI findings and movement disorders in patients treated with Sabril® (Vigabatrin).
Important Safety Information - Sabril (vigabatrin)